Long Term Efficacy of Left Atrial Appendage Closure with the Watchman Device

Overview

About this study

The purpose of this study is to evaluate the number of leaks from the LA into the LAA, and the size of each. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • All Watchman patients with at least one TEE following the initial device implantation

Exclusion Criteria: 

  • None

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Sorin Pislaru, M.D., Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available
.
CLS-20401453

Mayo Clinic Footer